Tag Archives: glp-1

Best of 2024: The Stories That Defined Longevity

January 11, 2025

Medicine stopped asking “what if” and started delivering “what’s next” in 2024.

Familiar drugs revealed new powers – GLP-1s protected brain tissue while reshaping metabolic health. Psychedelic therapy protocols moved from promising data to proven results. Anti-aging treatments once reserved for elite clinics found their way to neighborhood practices. Meanwhile, in pop-up enclaves across the globe, independent communities merged Web3 tools with longevity research, questioning every assumption about how science advances.

Yet, as medical possibilities soared to new heights, U.S. life expectancy data laid bare the chasm between medical capability and public health reality. This stark contrast forced hard questions about implementation – not just of new treatments, but of medical education itself.

Real-time analysis from the A4M Blog translated emerging science into practical guidance. From hormone optimization advances in menopause care to supplement safety investigations that exposed dangerous oversight gaps, each new revelation spurred meaningful progress in modern healthcare.

Continue reading →

The Drugs That Keep On Giving? Study Finds Unexpected Neuroprotective Benefits Of GLP-1 Agonists

July 21, 2024

In the ever-evolving landscape of medical science, certain discoveries stand out not just for their initial impact, but for their ability to continually reveal new and unexpected benefits. Glucagon-like peptide-1 receptor agonists (GLP-1 agonists) stand as prime examples of such pharmaceutical revelations. Initially developed for diabetes management and then repurposed for obesity treatment, these versatile compounds are now capturing attention for their potential cognitive benefits, further expanding their already impressive repertoire of clinical applications.

As the medical community increasingly focuses on brain health as a cornerstone of longevity, GLP-1 agonists have emerged as surprising contenders from an unexpected corner of pharmacology. This class of drugs, exemplified by semaglutide (marketed as Ozempic and Wegovy), challenges the conventional understanding of the intricate connections between metabolic health and cognitive longevity.

This latest chapter in the GLP-1 agonist saga is particularly significant given the growing concern over age-related cognitive decline and neurodegenerative diseases in an aging population. While lifestyle interventions such as diet and exercise remain foundational for brain health, the potential cognitive benefits of GLP-1 agonists represent an exciting new frontier in pharmacological approaches to healthy aging.

Continue reading →

Inaugural Insights for Clinical Success: Top Lessons From The A4M Weight Management Certification Program

May 25, 2024

Earlier this month, the first class of pioneering soon-to-be weight management experts gathered for the inaugural Clinical Weight Management Certification Program in Scottsdale, Arizona. This immersive experience was filled with insightful lectures, thought-provoking discussions, and engaging collaborative learning opportunities that left participants empowered and equipped with the critical knowledge and skills needed to navigate the complex weight management landscape. Amid the current obesity epidemic and craze surrounding Ozempic and similar “miracle” weight loss drugs, acquiring expertise in this field has become increasingly vital for healthcare providers across disciplines.

Renowned faculty members took the stage — including specialty leaders Ben Gonzaléz, MD, Gordon Crozier, DO, and James LaValle, RPh, CCN, MT — sharing their wealth of knowledge and presenting a practical, integrative approach to weight management. Drawing from their extensive experience as leaders in the functional and integrative weight management revolution, they provided attendees with easily applicable tools and protocols designed to achieve sustainable, long-term results for their patients.

Newly minted certification holders raved about the Clinical Weight Management Certification Program, citing its timeliness, relevance, esteemed faculty, and comprehensive scope as the primary reasons for their satisfaction. They praised the course’s ability to bridge the gap between the latest research and clinical application, providing a solid foundation for success in the ever-evolving field of weight management.

For those unable to attend, we’re delighted to offer a sneak peek into the transformative education this certification provides — before its second iteration occurs October 24-25 in Boston, MA.

Continue reading →